Cribstone Capital Management’s Novartis NVS Stock Holding History

Cribstone Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.45K	Hold	38	–	–	﹤0.01%	312
2022 Q3	$3K	Hold	38	–	–	﹤0.01%	327
2022 Q2	$3K	Buy	38 +12	+46%	+$1.05K	﹤0.01%	330
2022 Q1	$2K	Buy	26 +1	+4%	+$87	﹤0.01%	355
2021 Q4	$2K	Hold	25	–	–	﹤0.01%	350
2021 Q3	$2K	Hold	25	–	–	﹤0.01%	340
2021 Q2	$2K	Hold	25	–	–	﹤0.01%	318
2021 Q1	$2K	Hold	25	–	–	﹤0.01%	308
2020 Q4	$2K	Hold	25	–	–	﹤0.01%	297
2020 Q3	$2K	Hold	25	–	–	﹤0.01%	265
2020 Q2	$2K	Hold	25	–	–	﹤0.01%	295
2020 Q1	$2K	Hold	25	–	–	﹤0.01%	299
2019 Q4	$2K	Sell	25 -323	-93%	-$29K	﹤0.01%	347
2019 Q3	$30K	Sell	348 -200	-36%	-$18K	0.02%	282
2019 Q2	$50K	Sell	548 -180	-25%	-$15.2K	0.03%	243
2019 Q1	$63K	Sell	728 -468	-39%	-$37.6K	0.03%	207
2018 Q4	$92K	Hold	1,196	–	–	0.05%	181
2018 Q3	$92K	Hold	1,196	–	–	0.04%	200
2018 Q2	$81K	Sell	1,196 -341	-22%	-$23.5K	0.04%	212
2018 Q1	$111K	Buy	1,537 +223	+17%	+$17K	0.05%	176
2017 Q4	$99K	Buy	1,314 +281	+27%	+$21.2K	0.05%	203
2017 Q3	$79K	Sell	1,033 -197	-16%	-$14.9K	0.04%	203
2017 Q2	$92K	Sell	1,230 -220	-15%	-$15.6K	0.05%	195
2017 Q1	$96K	Buy	1,450 +633	+77%	+$42.2K	0.05%	201
2016 Q4	$52K	Hold	817	–	–	0.03%	257
2016 Q3	$56K	Hold	817	–	–	0.03%	248
2016 Q2	$60K	Buy	+817	New	+$56.4K	0.04%	246

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cribstone Capital Management's NVS Position: Q4 2022 in Review

Cribstone Capital Management held its Novartis (NVS) position steady in Q4 2022 at 38 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Cribstone Capital Management first reported a position in NVS in Q2 2016 and has held it in 27 quarters since. The position peaked at $111K in Q1 2018. 1,182 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

Cribstone Capital Management held 38 shares of Novartis worth $3.45K as of Q4 2022.
Cribstone Capital Management left its Novartis share count unchanged in Q4 2022.
Novartis made up ﹤0.01% of Cribstone Capital Management's portfolio in Q4 2022, its #312 holding.
Cribstone Capital Management first reported a position in Novartis in Q2 2016 and has held it in 27 quarters since.
Cribstone Capital Management's Novartis position peaked at $111K in Q1 2018.
1,182 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.